Robot stocks have surged repeatedly, and Tesla along with this timetable will be the "key in the coming period."

Chinese humanoid robot concept stocks have recently experienced a surge. On Wednesday, the 17th, the A-share market showed strong fluctuations throughout the day, the robotics sector continued its strong momentum, once again triggering a limit-up wave, and the chip industry chain rose steadily all day. Since September 5th, related industry chain stocks have averaged a 13.5% increase, far exceeding the market performance during the same period.

According to news from the Chasing Wind Trading Desk, Morgan Stanley's latest research report indicates that the core driving force behind this wave of market activity is the intensive dynamics of Tesla's Optimus and the latest advancements from global tech companies.

Morgan Stanley stated that on September 5th, Tesla announced a new incentive plan and a roadmap for mass production of humanoid robots, followed by a series of statements regarding the Optimus Gen3 and new production plans that continued to gain traction, driving value chain companies to outperform the market. At the same time, leading players like FigureAI released significant news forecasts, sparking high investor interest in the industry's commercialization breakthroughs.

In China, the release of orders has entered a concentrated window, with several integrators collectively signing large orders totaling nearly one billion yuan. Morgan Stanley analyzes that the current industry is undergoing a positive cycle of technological breakthroughs, order confirmations, and capital catalysis, with the market anticipating key developments from Tesla, FigureAI, and local unicorns in the next 2-3 months to provide continued momentum for the sector.

Tesla Ignites the Market, Value Chain Divergence Expands

Morgan Stanley noted that since September 5th, the humanoid robot industry chain stocks listed in China have achieved an astonishing increase of 13.5%, while the MSCI China Index only rose by 4.4% during the same period. Among them, companies related to the manufacturing of robot bodies performed particularly well, with an increase of up to 15.7%.

Behind this wave of fervent market activity are a series of significant signals released by Tesla and its CEO Elon Musk:

• September 5: Tesla proposed a long-term incentive plan for the CEO, one of the key operational milestones being the delivery of 1 million Optimus robots within the next 10 years.
• September 7: Tesla posted a picture of the Optimus Gen2.5 on Weibo, captioned "Accelerating Evolution," piquing market interest.
• September 10: At the All-In Summit, Musk revealed that the design of the Optimus Gen3 is in the final stages, with dexterity comparable to that of humans.
• September 16: Musk posted on the X platform stating that a meeting will be held at Tesla next week, focusing on the production plan for Optimus, artificial intelligence/autonomous driving, and vehicle production issues.

Global Competition Heats Up: FigureAI and Local Chinese Orders Relay

In addition to Tesla, competition in the global robotics field is also intensifying. Brett Adcock, CEO of the notable startup FigureAI, hinted on the X platform that the company will announce three major pieces of news within the next three days (starting from September 16), adding more imagination space to the market.

Meanwhile, the domestic humanoid robot industry in China is not just a concept. Key integrators are announcing more enterprise-level orders, providing solid evidence for the commercialization of the industry. According to statistics, the total amount of orders announced so far has approached 1 billion yuan.

Specifically (as of September 11), multiple companies, including Ubtech, Agibot, Unitree, AI^2 Robotics, and Astribot, have announced collaborations with clients such as China Mobile and manufacturing giant HKC, with a cumulative total order value of approximately 975 million yuan. The deployment of these orders is concentrated within the next two to three years, marking the transition of humanoid robots from the laboratory to real commercial application scenarios.

Morgan Stanley believes that as leading clients take the lead in validating the ROI of robots in manufacturing, logistics, and other areas, the accelerated commercialization and large-scale application is becoming a new trend in the industry